Meningococcal polysaccharide vaccine group A

Meningococcal polysaccharide vaccine group A Uses, Dosage, Side Effects, Food Interaction and all others data.

Meningococcal group A polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup A. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup A.

Trade Name Meningococcal polysaccharide vaccine group A
Generic Meningococcal polysaccharide vaccine group A
Meningococcal polysaccharide vaccine group A Other Names Meningococcal group A polysaccharide, Meningococcal polysaccharide antigen group A, Neisseria meningitidis group A capsular polysaccharide antigen, Neisseria meningitidis group A polysaccharide antigen, A
Type
Groups Approved, Experimental, Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Meningococcal polysaccharide vaccine group A
Meningococcal polysaccharide vaccine group A

Innovators Monograph

You find simplified version here Meningococcal polysaccharide vaccine group A

*** Taking medicines without doctor's advice can cause long-term problems.
Share